PT-141 10mg
Premium Compound
€25
Drive and arousal support without hormones — when libido and performance motivation are the research outcome.
Out of stock
Spetsifikatsioonid
| Sisu | 10 MG viaali kohta |
|---|---|
| Vorm | Lüofiliseeritud pulber |
| Puhtus | >99 % (laboris testitud) |
| Application | Ainult laboriuuringuteks |
Reconstitution calculator
Work out concentration, draw volume, and doses per vial. For laboratory research planning only.
How to read it: on a standard U-100 insulin syringe, 100 IU = 1 ml. The middle figure is the line to draw to. Always confirm against the research protocol. Products are sold for laboratory research use only, not for human consumption.
Description
PT-141 10mg is grouped under All Peptides, Performance for qualified laboratory use. Review availability and records on this product page before preparing materials.
Use the product fields above to confirm availability and the current live price for PT-141 10mg.
Show full research details
pt-141 10mg research overview
This page orients researchers to this catalog item within Performance. Use selector-driven records for variation-specific details rather than static copy alone.
Original catalog notes
PT-141 (Bremelanotide) is a melanocortin-receptor agonist studied specifically for libido and sexual-response pathways — a focused alternative to vascular approaches.
Why it stands out
- Acts on the central nervous system, not the vascular system
- Studied for libido and arousal in both sexes
- A well-characterised melanocortin compound
Supplied as dry powder, >99% purity, lab-tested with a certificate of analysis on every batch. For laboratory and research use only — not for human or animal consumption.
Catalog status
This Performance listing documents the item for laboratory planning. Confirm availability through the live catalog fields before preparing experiments.
Batch records and labeling
Laboratories cataloging materials under All Peptides, Performance should reconcile certificate data with physical labels before opening containers.
Study planning considerations
Design experiments so observations remain tied to selector-confirmed options. Treat descriptive text as orientation only.
External research references
Indexed publications may mention related research topics. Start with a PubMed literature search for pt-141 10mg for background review. These references are not clinical recommendations.
Storage and research-only scope
Store materials under conditions consistent with label and certificate guidance. Qualified personnel remain responsible for experimental design.
For laboratory and research use only. Catalog copy does not establish safety, efficacy, or suitability for personal use.
Review the physical label on PT-141 10mg against the order record before assigning an internal sample number.
Keep raw instrument output, preparation notes, and observation logs under the same study identifier to preserve a clear path from source material to reported result.
If a displayed document does not match the selected catalog option, pause the workflow and resolve the discrepancy before opening or preparing the material.
Storage conditions should be monitored according to the label and the laboratory's approved procedures, with deviations recorded in the sample history.
Independent literature can inform study design, but it does not verify the identity of a catalog item; that determination belongs to appropriate analytical testing.
Researchers should distinguish supplier documentation from their own findings and retain both records without presenting one as a substitute for the other.
Dispose of unused material and consumables under the laboratory's applicable procedures rather than relying on general product-page guidance.
Before any analytical run involving PT-141 10mg, cross-check certificates, internal sample logs, and preparation checklists maintained by the laboratory.
Research teams in Performance often archive selector screenshots and COA URLs alongside physical samples for audit trails.
When comparing related listings, prioritize identity confirmation and chain-of-custody notes over descriptive marketing language.
Laboratories should confirm that catalog records, environmental conditions, and instrument readouts remain linked to the same internal sample identifier through storage, preparation, and analysis.
Receipt identifiers, selector screenshots, and certificate URLs provide a practical audit trail when multiple catalog items from Performance are handled in parallel.
Record the date each container is received, inspected, and entered into inventory so later analytical reports can be reconciled with the correct material.
Any variation selected for a study should be documented before preparation begins; changing the selector later does not amend laboratory records already created.
Use calibrated equipment and validated methods appropriate to the planned analysis. Catalog descriptions do not replace method qualification or internal quality controls.
Review the physical label on PT-141 10mg against the order record before assigning an internal sample number.
